As part of its long-term investment in women’s sports, Eli Lilly will be present at the WNBA All-Star Game through breast cancer awareness activations.

A weekend focused on women’s health and women’s basketball, all in Eli Lilly’s home state of Indiana? Consider that a layup ...

Eli Lilly partners with breast cancer advocacy organisations to raise awareness of risk factors More than 290,000 women and men are expected to be diagnosed with breast cancer in the US in 2022 Eli ...

Eli Lilly’s latest campaign has new moves—yoga moves, that is. To raise awareness of metastatic breast cancer, Lilly Oncology has teamed up with “Good Morning America” on a new Thriver ...

More than 290,650 women and 2,710 men are expected to be diagnosed with breast cancer in the U.S. in 2022. 1 Resources often describe early stage breast cancer as treatable and survivable. However ...

Eli Lilly and Co. is pushing hard to gain a sales edge against two other drugmakers in the war against metastatic breast cancer. It is spending hundreds of millions of dollars to win over patients ...

-An estimated 113 people die every day in the U.S. from metastatic breast cancer. 1 This devastating statistic adds to the emotional and mental weight of living with incurable cancer.. Eli Lilly ...

Eli Lilly LLY announced results from the phase III EMBER-3 study, ... Sales of this drug have been rising, driven by strong demand in the early breast cancer (EBC) indication.

Study Overview: Eli Lilly and Company is conducting a clinical study titled ‘EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in ...

On Wednesday, Eli Lilly And Co (NYSE:LLY) announced results from the Phase 3 EMBER-3 study of imlunestrant for estrogen receptor-positive (ER+), human epidermal growth factor receptor 2 negative ...

Eli Lilly & Co. LLY on Friday released new clinical trial data on treatments for certain types of early breast cancer and mantle cell lymphoma. New analysis from a late-stage trial of Verzenio in ...

MADRID—If Eli Lilly could simply offer up an oral option in place of Faslodex for patients with breast cancer, Jacob Van Naarden would be pretty happy. Early evidence shows that the Indianapolis ...